These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22554278)

  • 1. Measurement of CYP1A2 activity: a focus on caffeine as a probe.
    Perera V; Gross AS; McLachlan AJ
    Curr Drug Metab; 2012 Jun; 13(5):667-78. PubMed ID: 22554278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of CYP1A2 activity in clinical practice: why, how, and when?
    Faber MS; Jetter A; Fuhr U
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):125-34. PubMed ID: 16128905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
    Fuhr U; Rost KL; Engelhardt R; Sachs M; Liermann D; Belloc C; Beaune P; Janezic S; Grant D; Meyer UA; Staib AH
    Pharmacogenetics; 1996 Apr; 6(2):159-76. PubMed ID: 9156694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
    Gu L; Gonzalez FJ; Kalow W; Tang BK
    Pharmacogenetics; 1992 Apr; 2(2):73-7. PubMed ID: 1302044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline has no advantages over caffeine as a putative model drug for assessing CYPIA2 activity in humans.
    Rasmussen BB; Brøsen K
    Br J Clin Pharmacol; 1997 Mar; 43(3):253-8. PubMed ID: 9088579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.
    Hakooz NM
    Curr Drug Metab; 2009 May; 10(4):329-38. PubMed ID: 19519341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
    Fuhr U; Rost KL
    Pharmacogenetics; 1994 Jun; 4(3):109-16. PubMed ID: 7920690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of toluidines and dinitrotoluenes on caffeine metabolic ratio in rat.
    Jodynis-Liebert J; Matuszewska A
    Toxicol Lett; 1999 Jan; 104(1-2):159-65. PubMed ID: 10048762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers.
    Shirley KL; Hon YY; Penzak SR; Lam YW; Spratlin V; Jann MW
    Neuropsychopharmacology; 2003 May; 28(5):961-6. PubMed ID: 12644842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women.
    Zaigler M; Rietbrock S; Szymanski J; Dericks-Tan JS; Staib AH; Fuhr U
    Int J Clin Pharmacol Ther; 2000 May; 38(5):235-44. PubMed ID: 10839467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
    Labedzki A; Buters J; Jabrane W; Fuhr U
    Biochem Pharmacol; 2002 Jun; 63(12):2159-67. PubMed ID: 12110375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.
    Buters JT; Tang BK; Pineau T; Gelboin HV; Kimura S; Gonzalez FJ
    Pharmacogenetics; 1996 Aug; 6(4):291-6. PubMed ID: 8873215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
    Yu T; Campbell SC; Stockmann C; Tak C; Schoen K; Clark EA; Varner MW; Spigarelli MG; Sherwin CM
    J Clin Pharmacol; 2016 May; 56(5):590-6. PubMed ID: 26358647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
    Spigset O; Hägg S; Söderström E; Dahlqvist R
    Pharmacogenetics; 1999 Jun; 9(3):409-12. PubMed ID: 10471076
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease and CYP1A2 activity.
    Forsyth JT; Grünewald RA; Rostami-Hodjegan A; Lennard MS; Sagar HJ; Tucker GT
    Br J Clin Pharmacol; 2000 Oct; 50(4):303-9. PubMed ID: 11012552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
    Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
    Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.